Developer docs
API playgroundTry for free, no card

Search company profiles

SparkBio

Full company profile

uuid002cstt

Namestring
SparkBio
Legal namestring
SparkBio
Websiteurl
sparkbio.it
Company typeenum
Private
Founded yearint
1995
Descriptiontext

SparkBio S.r.l. is a privately-held Italian medical technology company founded in 1995 and headquartered in San Lazzaro di Savena, near Bologna. The firm operates with a small team (1-10 employees) and combines proprietary medical device engineering with exclusive distribution and authorized service for third-party products. Its current commercial offering is anchored by two pillars: (i) the Finapres NOVA, a CE-marked non-invasive continuous blood pressure monitor with a 13-inch touch screen, double finger cuff system for 24/7 patient-friendly measurement, and a modular architecture expandable with additional hardware modules and software applications, distributed by SparkBio as the exclusive Italian partner of Finapres Medical Systems B.V.; and (ii) OneViewX, a proprietary medical-grade software platform for recording, streaming, editing, and sharing video and analog signals captured in surgical and interventional rooms, marketed to surgical and cardiology departments seeking to establish Permanent Live Case Centers for remote clinical education.

The company's revenue model blends hardware sales (Finapres NOVA monitors, finger cuffs, and accessories), recurring aftermarket services (exclusive authorized maintenance, calibration, spare parts, and repair for both current and legacy Finapres devices installed in Italy — Finometer PRO, Finometer MIDI, and Portapres), and proprietary software (OneViewX). Go-to-market is enterprise field sales targeting hospitals, cardiology and neurology departments, neurophysiology laboratories, and clinical research institutions, augmented by direct inbound via website and email and a separate oneviewx.com digital presence for international outreach. Historically, SparkBio developed CE-marked neurovascular polygraphic systems for syncope/neurological disease study and a patented automatic carbon dioxide angiography system (CE-marked end-2011); both remain part of the legacy portfolio. Pricing is quote-based and not publicly disclosed, with SparkBio offering customized configurations of the Finapres NOVA platform.

Strategically, SparkBio has shifted emphasis since 2014 toward its OneViewX software platform while maintaining the lucrative Finapres exclusive distribution and authorized-service franchise in Italy. The firm holds one granted patent (automatic CO2 angiography system), multiple CE marks, and 25 years of clinical relationships, but operates at sub-10 headcount with no disclosed institutional backing, funding events, or named customer logos in the available record. Source IDs primarily supporting these facts include (firmographic profile and product positioning) (technology, history, and proprietary systems) (Finapres NOVA details and distribution agreement) (channel partnership and distribution scope), (OneViewX product positioning).

Short descriptiontext

SparkBio is a privately-held Italian medical technology firm (founded 1995, Bologna) that is the exclusive Italian distributor of the Finapres NOVA non-invasive blood pressure monitor and the developer of OneViewX, a proprietary medical-grade video and signal acquisition platform used in surgical rooms for remote clinical education.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Lazzaro Di Savena, Italy
HQ citystring
San Lazzaro Di Savena
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device distribution, non-invasive blood pressure monitoring, surgical video acquisition, neurovascular diagnostics, cardiology medical technology
Industry3 codes
1Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
CodeHLAHAFAIPrimaryYes
2Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
CodeHLALAFAAPrimaryNo
3Cardiology Telemedicine Platforms
CodeHLALAGABPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Distribution
TypeHardware Sales
Description

Exclusive distribution of Finapres Medical Systems products in Italy including the NOVA blood pressure monitor, finger cuffs, and related accessories. Revenue generated from product sales with 25 years of industry experience supporting configuration and sales.

sparkbio.it
2Proprietary Software Platforms
TypeSubscription Recurring
Description

Sales of proprietary software including OneViewX for video/signal acquisition in surgical environments and cardiac rehabilitation management platforms. Marketed in selected markets worldwide.

sparkbio.it
3Maintenance and Calibration Services
TypeProfessional Services
Description

Exclusive authorized partner managing maintenance, repairs, calibration, and spare parts for Finapres devices in Italy. Covers legacy devices including Finometer PRO, Finometer MIDI, and Portapres.

sparkbio.it
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1OneViewX
Description

A modern software technology for video and analog signals acquisition at surgery and interventional rooms, designed to enable Permanent Live Case Centers for Remote Education and Support.

sparkbio.it
Core offering1 text field

SparkBio develops proprietary medical technology for cardiology and neurology applications, including the OneViewX surgical video and signal acquisition platform. The company serves as the Italian exclusive distributor for Finapres Medical Systems B.V., handling sales, installation, and authorized maintenance of the Finapres NOVA non-invasive continuous blood pressure monitor. SparkBio also provides maintenance, calibration, and spare parts services for the installed Finapres device base in Italy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Non-invasive continuous blood pressure measurement available 24/7 with patient-friendly finger cuff technology
+1 more record
Product overview1 text field

SparkBio operates as a medical technology company offering a portfolio of proprietary medical devices and software. The current core products are the Finapres NOVA (a modular non-invasive continuous blood pressure monitoring system distributed exclusively in Italy) and the OneViewX platform (a medical-grade video/analog signal recording, streaming, editing, and sharing system for surgical and interventional rooms). Historically, the company also developed CE-marked neurovascular polygraphic systems, a carbon dioxide angiography system, and cardiac rehabilitation software, and currently supports legacy installed bases through authorized repair and calibration services.

Product and service7 records
1Finapres NOVA
CategoryNon-invasive blood pressure monitor
Description

A cutting-edge non-invasive continuous blood pressure monitor featuring a 13-inch touch screen, a double finger cuff system enabling 24/7 patient-friendly measurement, and a modular architecture allowing expansion with hardware modules and software applications. SparkBio is the Italian exclusive distributor for hospitals, cardiology departments, and clinical research institutions.

2OneViewX
CategoryMedical video acquisition software
Description

A medical-grade software platform for recording, streaming, editing, and sharing surgical and interventional procedures, enabling Permanent Live Case Centers for remote clinical education and support worldwide. Designed for surgical departments, interventional radiology/cardiology centers, and clinical educators.

3Finapres Repairs & Calibration Services
CategoryMedical device maintenance services
Description

Authorized maintenance, calibration, and spare parts (HCU, Finger Cuff, other accessories) services for Finapres devices installed in Italy, including discontinued Finometer PRO, Finometer MIDI, and Portapres models.

4Neurovascular Polygraphic Systems
CategoryNeurovascular diagnostic systems
Description

Proprietary CE-marked neurovascular polygraphic systems for the study of syncope and neurological diseases, originally developed in 1995 and marketed exclusively in selected markets worldwide.

5Carbon Dioxide Angiography System
CategoryAngiography system
Description

A patented and exclusive automatic system for carbon dioxide angiography, CE-marked in 2011, used for imaging in endovascular procedures as a radiation-free alternative.

6Cardiac Rehabilitation Management Software
CategoryCardiac rehabilitation software
Description

A software platform for cardiac rehabilitation management in hospital gyms and at home, developed starting in 2008.

7Syncope Unit and Neurophysiology Laboratory Suite
CategoryDiagnostic laboratory suite
Description

A complete suite of products and services for Syncope Units and Neurophysiology laboratories, rationalized in 2011 as part of the company's core business restructuring.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2011-01-01
Description

SparkBio is the Italian exclusive distributor for Finapres Medical Systems B.V. Since 2011, SparkBio has handled national distribution of Finapres products including the NOVA blood pressure monitor. The company also serves as the exclusive authorized partner to manage all maintenance on existing installed Finapres devices in Italy, including legacy products (Finometer PRO, Finometer MIDI, Portapres) and provides spare parts, calibration services, and repairs.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Caretaker Medical builds a wireless, cuffless continuous non-invasive blood pressure monitor using finger-PPG technology, a direct technological analogue of the Finapres NOVA's continuous finger-cuff approach and serving the same hemodynamic monitoring use cases.

TypeDirect peer
Description

Proximie is a remote surgical collaboration platform that allows surgeons to virtually scrub into procedures, share expertise, and educate peers worldwide, overlapping directly with OneViewX's Permanent Live Case Center model for interventional rooms.

TypeBroad incumbent
Description

Edwards is a global leader in hemodynamic and critical care monitoring, with invasive and minimally invasive platforms (e.g., FloTrac, ClearSight) that compete against Finapres-style non-invasive continuous BP in the same cath lab, OR, and ICU segments.

TypeEmerging player
Description

Biobeat makes wearable, cuffless continuous blood pressure and vital sign monitors for hospital and remote patient monitoring, overlapping with the Finapres NOVA's continuous BP use case and the broader cardiometabolic RPM trend SparkBio touches through Finapres and its legacy cardiac rehab software.

TypeDirect peer
Description

Uscom develops non-invasive cardiovascular monitoring devices (USCOM 1A, BP+) used for hemodynamics, sepsis, and hypertension management, providing a direct technological parallel to the Finapres NOVA in the cardiology and critical care monitoring space.

TypeBroad incumbent
Description

LiDCO, now part of Masimo, offers non-invasive and minimally invasive hemodynamic monitoring technologies, including continuous BP and cardiac output. It is a direct functional competitor to the Finapres NOVA in hemodynamic monitoring.

TypeBroad incumbent
Description

Brainlab provides integrated surgical video capture, OR digitization, and remote collaboration tools used by hospitals and surgeons globally, broadly competing with the OneViewX platform while also serving neurosurgery and interventional workflows SparkBio addresses.

TypeDirect peer
Description

Deltex Medical provides non-invasive and minimally invasive hemodynamic monitoring (oesophageal Doppler, TrueVue) to clinicians, overlapping with the Finapres NOVA and the neurovascular diagnostic workflow SparkBio supports in cardiology and neurology.

TypeDirect peer
Description

CNSystems develops non-invasive hemodynamic monitoring solutions including continuous blood pressure and cardiac output, overlapping directly with the Finapres NOVA product family. Both companies target the same clinical hemodynamic monitoring use case in hospitals and research institutions.

TypeDirect peer
Description

Finapres is the manufacturer of the Finapres NOVA and the originator of the non-invasive continuous blood pressure technology that SparkBio distributes in Italy. While it is also SparkBio's supplier, it is the most direct comparability anchor because its products define the category SparkBio sells into.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SparkBio

Medical Devicessparkbio.it

SparkBio is a privately-held Italian medical technology firm (founded 1995, Bologna) that is the exclusive Italian distributor of the Finapres NOVA non-invasive blood pressure monitor and the developer of OneViewX, a proprietary medical-grade video and signal acquisition platform used in surgical rooms for remote clinical education.

What SparkBio does

SparkBio S.r.l. is a privately-held Italian medical technology company founded in 1995 and headquartered in San Lazzaro di Savena, near Bologna. The firm operates with a small team (1-10 employees) and combines proprietary medical device engineering with exclusive distribution and authorized service for third-party products. Its current commercial offering is anchored by two pillars: (i) the Finapres NOVA, a CE-marked non-invasive continuous blood pressure monitor with a 13-inch touch screen, double finger cuff system for 24/7 patient-friendly measurement, and a modular architecture expandable with additional hardware modules and software applications, distributed by SparkBio as the exclusive Italian partner of Finapres Medical Systems B.V.; and (ii) OneViewX, a proprietary medical-grade software platform for recording, streaming, editing, and sharing video and analog signals captured in surgical and interventional rooms, marketed to surgical and cardiology departments seeking to establish Permanent Live Case Centers for remote clinical education.

The company's revenue model blends hardware sales (Finapres NOVA monitors, finger cuffs, and accessories), recurring aftermarket services (exclusive authorized maintenance, calibration, spare parts, and repair for both current and legacy Finapres devices installed in Italy — Finometer PRO, Finometer MIDI, and Portapres), and proprietary software (OneViewX). Go-to-market is enterprise field sales targeting hospitals, cardiology and neurology departments, neurophysiology laboratories, and clinical research institutions, augmented by direct inbound via website and email and a separate oneviewx.com digital presence for international outreach. Historically, SparkBio developed CE-marked neurovascular polygraphic systems for syncope/neurological disease study and a patented automatic carbon dioxide angiography system (CE-marked end-2011); both remain part of the legacy portfolio. Pricing is quote-based and not publicly disclosed, with SparkBio offering customized configurations of the Finapres NOVA platform.

Strategically, SparkBio has shifted emphasis since 2014 toward its OneViewX software platform while maintaining the lucrative Finapres exclusive distribution and authorized-service franchise in Italy. The firm holds one granted patent (automatic CO2 angiography system), multiple CE marks, and 25 years of clinical relationships, but operates at sub-10 headcount with no disclosed institutional backing, funding events, or named customer logos in the available record. Source IDs primarily supporting these facts include (firmographic profile and product positioning) (technology, history, and proprietary systems) (Finapres NOVA details and distribution agreement) (channel partnership and distribution scope), (OneViewX product positioning).

SparkBio firmographics

Firmographics
Name
SparkBio
Legal name
SparkBio
Website
https://sparkbio.it
Company type
Private
Founded year
1995
Operating status
Operating
Headcount range
1–10 employees
Short description
SparkBio is a privately-held Italian medical technology firm (founded 1995, Bologna) that is the exclusive Italian distributor of the Finapres NOVA non-invasive blood pressure monitor and the developer of OneViewX, a proprietary medical-grade video and signal acquisition platform used in surgical rooms for remote clinical education.
Ownership category
akta.pro rank

SparkBio industry classification

Industry
Product category
Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
akta.pro secondary industries
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Cardiology Telemedicine Platforms (HLALAGAB)

Keywords

  • Medical device distribution
  • Non-invasive blood pressure monitoring
  • Surgical video acquisition
  • Neurovascular diagnostics
  • Cardiology medical technology

Where SparkBio is headquartered

Location

Headquarters

HQ city
San Lazzaro Di Savena
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

SparkBio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Medical Device Distribution: Exclusive distribution of Finapres Medical Systems products in Italy including the NOVA blood pressure monitor, finger cuffs, and related accessories. Revenue generated from product sales with 25 years of industry experience supporting configuration and sales.
  2. Proprietary Software Platforms: Sales of proprietary software including OneViewX for video/signal acquisition in surgical environments and cardiac rehabilitation management platforms. Marketed in selected markets worldwide.
  3. Maintenance and Calibration Services: Exclusive authorized partner managing maintenance, repairs, calibration, and spare parts for Finapres devices in Italy. Covers legacy devices including Finometer PRO, Finometer MIDI, and Portapres.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

SparkBio product offering

Product offering

Core offering

SparkBio develops proprietary medical technology for cardiology and neurology applications, including the OneViewX surgical video and signal acquisition platform. The company serves as the Italian exclusive distributor for Finapres Medical Systems B.V., handling sales, installation, and authorized maintenance of the Finapres NOVA non-invasive continuous blood pressure monitor. SparkBio also provides maintenance, calibration, and spare parts services for the installed Finapres device base in Italy.

Product overview

SparkBio operates as a medical technology company offering a portfolio of proprietary medical devices and software. The current core products are the Finapres NOVA (a modular non-invasive continuous blood pressure monitoring system distributed exclusively in Italy) and the OneViewX platform (a medical-grade video/analog signal recording, streaming, editing, and sharing system for surgical and interventional rooms). Historically, the company also developed CE-marked neurovascular polygraphic systems, a carbon dioxide angiography system, and cardiac rehabilitation software, and currently supports legacy installed bases through authorized repair and calibration services.

Differentiator

Problem solved

Functional benefit

Brands

  • OneViewX: A modern software technology for video and analog signals acquisition at surgery and interventional rooms, designed to enable Permanent Live Case Centers for Remote Education and Support.

Products and services

  • Finapres NOVA A cutting-edge non-invasive continuous blood pressure monitor featuring a 13-inch touch screen, a double finger cuff system enabling 24/7 patient-friendly measurement, and a modular architecture allowing expansion with hardware modules and software applications. SparkBio is the Italian exclusive distributor for hospitals, cardiology departments, and clinical research institutions.
  • OneViewX A medical-grade software platform for recording, streaming, editing, and sharing surgical and interventional procedures, enabling Permanent Live Case Centers for remote clinical education and support worldwide. Designed for surgical departments, interventional radiology/cardiology centers, and clinical educators.
  • Finapres Repairs & Calibration Services Authorized maintenance, calibration, and spare parts (HCU, Finger Cuff, other accessories) services for Finapres devices installed in Italy, including discontinued Finometer PRO, Finometer MIDI, and Portapres models.
  • Neurovascular Polygraphic Systems Proprietary CE-marked neurovascular polygraphic systems for the study of syncope and neurological diseases, originally developed in 1995 and marketed exclusively in selected markets worldwide.
  • Carbon Dioxide Angiography System A patented and exclusive automatic system for carbon dioxide angiography, CE-marked in 2011, used for imaging in endovascular procedures as a radiation-free alternative.
  • Cardiac Rehabilitation Management Software A software platform for cardiac rehabilitation management in hospital gyms and at home, developed starting in 2008.
  • Syncope Unit and Neurophysiology Laboratory Suite A complete suite of products and services for Syncope Units and Neurophysiology laboratories, rationalized in 2011 as part of the company's core business restructuring.

Quantifiable outcome

  • Non-invasive continuous blood pressure measurement available 24/7 with patient-friendly finger cuff technology
  • +1 more outcomes

Companies that use SparkBio

Customer profile

Segments4 records

Ideal customer profiles4 records

SparkBio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

SparkBio partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Finapres Medical Systems B.V.coreChannel Partner/ Reseller/ Distributor · 1 January 2011SparkBio is the Italian exclusive distributor for Finapres Medical Systems B.V. Since 2011, SparkBio has handled national distribution of Finapres products including the NOVA blood pressure monitor. The company also serves as the exclusive authorized partner to manage all maintenance on existing installed Finapres devices in Italy, including legacy products (Finometer PRO, Finometer MIDI, Portapres) and provides spare parts, calibration services, and repairs.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

SparkBio competitors and assessment

Company assessment

Emerging players

  • Caretaker Medical: Caretaker Medical builds a wireless, cuffless continuous non-invasive blood pressure monitor using finger-PPG technology, a direct technological analogue of the Finapres NOVA's continuous finger-cuff approach and serving the same hemodynamic monitoring use cases.
  • Biobeat Technologies: Biobeat makes wearable, cuffless continuous blood pressure and vital sign monitors for hospital and remote patient monitoring, overlapping with the Finapres NOVA's continuous BP use case and the broader cardiometabolic RPM trend SparkBio touches through Finapres and its legacy cardiac rehab software.

Direct peers

  • Proximie: Proximie is a remote surgical collaboration platform that allows surgeons to virtually scrub into procedures, share expertise, and educate peers worldwide, overlapping directly with OneViewX's Permanent Live Case Center model for interventional rooms.
  • Uscom Limited: Uscom develops non-invasive cardiovascular monitoring devices (USCOM 1A, BP+) used for hemodynamics, sepsis, and hypertension management, providing a direct technological parallel to the Finapres NOVA in the cardiology and critical care monitoring space.
  • Deltex Medical Group plc: Deltex Medical provides non-invasive and minimally invasive hemodynamic monitoring (oesophageal Doppler, TrueVue) to clinicians, overlapping with the Finapres NOVA and the neurovascular diagnostic workflow SparkBio supports in cardiology and neurology.
  • CNSystems Medizintechnik AG: CNSystems develops non-invasive hemodynamic monitoring solutions including continuous blood pressure and cardiac output, overlapping directly with the Finapres NOVA product family. Both companies target the same clinical hemodynamic monitoring use case in hospitals and research institutions.
  • Finapres Medical Systems B.V. Finapres is the manufacturer of the Finapres NOVA and the originator of the non-invasive continuous blood pressure technology that SparkBio distributes in Italy. While it is also SparkBio's supplier, it is the most direct comparability anchor because its products define the category SparkBio sells into.

Broad incumbents

  • Edwards Lifesciences: Edwards is a global leader in hemodynamic and critical care monitoring, with invasive and minimally invasive platforms (e.g., FloTrac, ClearSight) that compete against Finapres-style non-invasive continuous BP in the same cath lab, OR, and ICU segments.
  • LiDCO (Masimo): LiDCO, now part of Masimo, offers non-invasive and minimally invasive hemodynamic monitoring technologies, including continuous BP and cardiac output. It is a direct functional competitor to the Finapres NOVA in hemodynamic monitoring.
  • Brainlab: Brainlab provides integrated surgical video capture, OR digitization, and remote collaboration tools used by hospitals and surgeons globally, broadly competing with the OneViewX platform while also serving neurosurgery and interventional workflows SparkBio addresses.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

SparkBio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SparkBio leadership team

Management profile

Number of profiles

SparkBio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SparkBio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SparkBio

What does SparkBio do?

SparkBio develops proprietary medical technology for cardiology and neurology applications, including the OneViewX surgical video and signal acquisition platform. The company serves as the Italian exclusive distributor for Finapres Medical Systems B.V., handling sales, installation, and authorized maintenance of the Finapres NOVA non-invasive continuous blood pressure monitor. SparkBio also provides maintenance, calibration, and spare parts services for the installed Finapres device base in Italy.

Is SparkBio a public or private company?

SparkBio is a private company. It is classified as unknown and is currently operating.

When was SparkBio founded?

SparkBio was founded in 1995. It employs 1 to 10 people.

Where is SparkBio based?

SparkBio is headquartered in San Lazzaro Di Savena, Italy, in the Europe region.

How does SparkBio make money?

Three revenue lines are on record. Medical Device Distribution is the primary driver. The others are proprietary Software Platforms and maintenance and Calibration Services.

Who are SparkBio's main competitors?

Emerging players on record are Caretaker Medical and Biobeat Technologies. Direct peers are Proximie, Uscom Limited, Deltex Medical Group plc, CNSystems Medizintechnik AG and Finapres Medical Systems B.V.. Broad incumbents are Edwards Lifesciences, LiDCO (Masimo) and Brainlab.

Does SparkBio have an API?

No public API is recorded for SparkBio.

What industry is SparkBio in?

SparkBio's product category is Medical Devices. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales